Conecte-se

Bibliografias temáticas / Diagnostic and prognostic marker / Livros

Siga este link para ver outros tipos de publicações sobre o tema: Diagnostic and prognostic marker.

Livros sobre o tema "Diagnostic and prognostic marker"

Autor: Grafiati

Publicado: 14 de março de 2023

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos

Selecione um tipo de fonte:

Veja os 50 melhores livros para estudos sobre o assunto "Diagnostic and prognostic marker".

Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.

Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.

Veja os livros das mais diversas áreas científicas e compile uma bibliografia correta.

1

Diagnostic and prognostic biomarkers and therapeutic targets in melanoma. Totowa, N.J: Humana, 2012.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

2

Russo, Antonio, Stefano Iacobelli e Juan Iovanna, eds. Diagnostic, Prognostic and Therapeutic Value of Gene Signatures. Totowa, NJ: Humana Press, 2012. http://dx.doi.org/10.1007/978-1-61779-358-5.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

3

Nieto, Mark E. Naval aviation aging wiring: Prognostic and diagnostic solutions. Monterey, Calif: Naval Postgraduate School, 2000.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

4

Hughes, Mark D. Point-of-care testing: Status and prognosis. Waltham, MA: Decision Resources, 1996.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

5

Murphy, Michael J., ed. Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-60761-433-3.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

6

K, Pantel, ed. Minimal residual epithelial cancer: Diagnostic approaches and prognostic relevance. Stuttgart: Gustav Fischer Verlag, 1996.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

7

Jemeï, Samir. Hybridization, Diagnostic and Prognostic of Proton Exchange Membrane Fuel Cells. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2018. http://dx.doi.org/10.1002/9781119563426.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

8

CNS cancer: Models, markers, prognostic factors, targets, and therapeutic approaches. Central nervous system cancer: Humana Press, 2009.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

9

The clinical marker hCG. New York: Praeger, 1987.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

10

Sevelius, Ewa. Chronic liver disease in the dog: A demographic, aetiologic, diagnostic and prognostic study. Uppsala: Sveriges Lantbruksuniversitet, 1995.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

11

Giampietro, Gasparini, e Hayes Daniel 1951-, eds. Biomarkers in breast cancer: Molecular diagnostics for predicting and monitoring therapeutic effect. Totowa, N.J: Humana Press, 2006.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

12

Cerullo, Dante. Identification of a novel diagnostic marker for viral myocarditis using cDNA microarrays. Ottawa: National Library of Canada, 2003.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

13

1928-, Ehrlich George E., e Gallacchi G, eds. The elderly rheumatic patient: Diagnostic, prognostic, and therapeutic aspects : report of a symposium held during the XIth European Congress of Rheumatology, Athens, 1987. Toronto: Huber, 1989.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

14

M, Gratzl, e Langley Keith, eds. Markers for neural and endocrine cells: Molecular and cell biology, diagnostic applications. Weinheim (Federal Republic of Germany): VCH, 1990.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

15

Mouriquand, Jacqueline. Diagnosis of non-palpable breast lesions: Ultrasonographically controlled fine-needle aspiration : diagnostic and prognostic implications of cytologic grading, morphometry, DNA cytometry, immunocytochemistry, and color doppler. Basel: Karger, 1993.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

16

Mouriquand, Jacqueline. Diagnosis of non-palpable breast lesions: Ultrasonographically controlled fine-needle aspirations : diagnostic and prognostic implications of cytologic grading, morphometry, DNA cytometry, immunocytochemistry, and color doppler. Basel: Karger, 1993.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

17

Kim, Ho-jung. array-CGH rŭl iyong han piso sepʻo pʻyeam ŭi chogi chaebal pʻyojija mit chindan mohyŏng kaebal =: Development of early-recurrence detection marker and diagnostic model using array-CGH in NSCLC. [Seoul]: Pogŏn Pokchibu, 2007.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

18

Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer – Illumination of a Vision. MDPI, 2019. http://dx.doi.org/10.3390/books978-3-03897-635-6.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

19

Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer – Illumination of a Vision 2.0. MDPI, 2021. http://dx.doi.org/10.3390/books978-3-03943-686-6.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

20

Sholl, Lynette. Molecular Pathology: Predictive, Prognostic, and Diagnostic Markers in Tumors, an Issue of Surgical Pathology Clinics. Elsevier - Health Sciences Division, 2016.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

21

Freedman, Mark S., e Mohammad Abdoli. The Importance and Utility of Cerebrospinal Fluid Evaluation in the Diagnosis of Central Demyelinating Diseases. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199341016.003.0008.

Texto completo da fonte

Resumo:

This chapter aims to highlight the diagnostic and prognostic value of cerebrospinal fluid (CSF) findings in multiple sclerosis with a special consideration of distinguishing it from neuromyelitis optica (NMO) and NMO spectrum disorder. Interpretation of CSF findings in daily clinical practice in patients with MS is thoroughly explained. New advances in CSF analysis and recently identified biomarkers may be helpful for diagnosis, help elucidate disease subtype and activity, or aid in prognosis and monitoring of the response to treatment. Characteristics of CSF changes in different subtypes of multiple sclerosis, clinically isolated syndrome (CIS), and radiologically isolated syndrome (RIS) are discussed. CSF findings in NMO spectrum disease as a diagnostic and differentiating marker are explained separately.

Estilos ABNT, Harvard, Vancouver, APA, etc.

22

(Contributor), A. Burkhardt, J. K. Field (Contributor), N. W. Johnson (Contributor), R.C.K. Jordan (Contributor), P. A. Reichart (Contributor), A.G.M. Scholes (Contributor), C. Scully (Contributor) et al., eds. Oral Pathology: Actual Diagnostic and Prognostic & Prognostic Aspects. Springer, 1996.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

23

GOHEL, Hardik. CEA - Prognostic Marker for Breast Cancer. Independently Published, 2019.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

24

Biomarkers In Oncology Prediction And Prognosis. Springer, 2012.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

25

Jin, J. P. Troponin: Informative Diagnostic Marker. Nova Science Publishers, Incorporated, 2014.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

26

Sharma, Rohan, Amitha M. Hegde e Rajmohan Shetty. Prognostic and diagnostic potential of cephalometrics. LAP Lambert Academic Publishing, 2018.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

27

Prognostic Markers in Hematologic Oncology. Informa Healthcare, 2005.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

28

Seifert, Gerhard, N. W. Johnson, A. Burkhardt, J. K. Field e R. C. K. Jordan. Oral Pathology: Actual Diagnostic and Prognostic Aspects. Springer London, Limited, 2012.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

29

Oral pathology: Actual diagnostic and prognostic aspects. Berlin: Springer, 1996.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

30

Oral Pathology Actual Diagnostic And Prognostic Aspects. Springer, 2012.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

31

Knickerbocker, Tanya Lynn. Protein microarrays as diagnostic and prognostic tools. 2009.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

32

Diagnostic, Prognostic and Predictive Biomarkers in Prostate Cancer. MDPI, 2017. http://dx.doi.org/10.3390/books978-3-03842-633-2.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

33

Ehrlich, George E. Elderly Rheumatic Patient: Diagnostic, Prognostic and Therapeutic Aspects. Hogrefe & Huber Publishers, 1989.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

34

Troup, Francis. Sputum, Its Microscopy and Diagnostic and Prognostic Significations. Creative Media Partners, LLC, 2018.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

35

Naval Aviation Aging Wiring: Prognostic and Diagnostic Solutions. Storming Media, 2000.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

36

Stephan, Carsten. Diagnostic, Prognostic and Predictive Biomarkers in Prostate Cancer. Mdpi AG, 2018.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

37

Russo, Antonio, Juan Iovanna e Stefano Iacobelli. Diagnostic, Prognostic and Therapeutic Value of Gene Signatures. Humana Press, 2011.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

38

Russo, Antonio, Juan Iovanna e Stefano Iacobelli. Diagnostic, Prognostic and Therapeutic Value of Gene Signatures. Humana Press, 2011.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

39

Russo, Antonio, Juan Iovanna e Stefano Iacobelli. Diagnostic, Prognostic and Therapeutic Value of Gene Signatures. Humana Press, 2016.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

40

Gakis, Georgios, e Arnulf Stenzl. Molekulare Marker beim high-grade Harnblasenkarzinom: Diagnostisch - prognostisch - prädiktiv. Springer, 2016.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

41

Ehrlich, George. The Elderly Rheumatic Patient: Diagnostic, Prognostic, and Therapeutic Aspects. Hans Huber Pub, 1989.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

42

J, Murphy Michael. Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma. Springer, 2011.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

43

J, Murphy Michael. Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma. Springer, 2011.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

44

J, Murphy Michael. Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma. Humana, 2016.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

45

Pierard, Luc A., e Lauro Cortigiani. Stress echocardiography: diagnostic and prognostic values and specific clinical subsets. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198726012.003.0015.

Texto completo da fonte

Resumo:

Stress echocardiography is a widely used method for assessing coronary artery disease, due to its high diagnostic and prognostic value. While inducible ischaemia predicts an unfavourable outcome, its absence is associated with a low risk of future cardiac events. The method provides superior diagnostic and prognostic information than standard exercise electrocardiography and perfusion myocardial imaging in specific clinical subsets, such as women, hypertensive patients, and patients with left bundle branch block. Stress echocardiography allows effective risk assessment also in the diabetic population. The evaluation of coronary flow reserve of the left anterior descending artery by transthoracic Doppler adds diagnostic and prognostic information to that of standard stress test. Stress echocardiography is indicated in the cases when exercise electrocardiography is unfeasible, uninterpretable or gives ambiguous result, and when ischaemia during the test is frequently a false-positive response, as in hypertensive patients, women, and patients with left ventricular hypertrophy. Viability detection represents another application of stress echocardiography. The documentation of a large amount of viable myocardium predicts improved ejection fraction, reverse remodelling, and improved outcome following revascularization in patients with ischaemic cardiomyopathy. Moreover, stress echocardiography can aid significantly in clinical decision-making in patients with valvular heart disease through dynamic assessment of primary or secondary mitral regurgitation, transvalvular gradients, and pulmonary artery systolic pressure, as well as before vascular surgery due to the excellent negative predictive value. Finally, stress echocardiography allows effective risk stratification in patients with hypertrophic cardiomyopathy through evaluation of inducible ischaemia, coronary flow reserve, and intraventricular gradient.

Estilos ABNT, Harvard, Vancouver, APA, etc.

46

Biomarkers in breast cancer: Molecular diagnostics for predicting and monitoring therapeutic effect. Totowa, N.J: Humana Press, 2006.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

47

Verma, Mukesh, Debmalya Barh, Angelo Carpi e Mehmet Gunduz. Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis. Taylor & Francis Group, 2014.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

48

Barh, Debmalya. Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis. Taylor & Francis Group, 2014.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

49

Verma, Mukesh, Debmalya Barh, Angelo Carpi e Mehmet Gunduz. Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis. Taylor & Francis Group, 2017.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

50

Verma, Mukesh, Debmalya Barh, Angelo Carpi e Mehmet Gunduz. Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis. Taylor & Francis Group, 2014.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Oferecemos descontos em todos os planos premium para autores cujas obras estão incluídas em seleções literárias temáticas. Contate-nos para obter um código promocional único!